These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9096347)

  • 1. Target of rapamycin proteins and their kinase activities are required for meiosis.
    Zheng XF; Schreiber SL
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3070-5. PubMed ID: 9096347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins.
    Hardwick JS; Kuruvilla FG; Tong JK; Shamji AF; Schreiber SL
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14866-70. PubMed ID: 10611304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.
    Crespo JL; Hall MN
    Microbiol Mol Biol Rev; 2002 Dec; 66(4):579-91, table of contents. PubMed ID: 12456783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
    Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
    J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOR controls translation initiation and early G1 progression in yeast.
    Barbet NC; Schneider U; Helliwell SB; Stansfield I; Tuite MF; Hall MN
    Mol Biol Cell; 1996 Jan; 7(1):25-42. PubMed ID: 8741837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
    Sabatini DM; Pierchala BA; Barrow RK; Schell MJ; Snyder SH
    J Biol Chem; 1995 Sep; 270(36):20875-8. PubMed ID: 7673106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEAT repeats mediate plasma membrane localization of Tor2p in yeast.
    Kunz J; Schneider U; Howald I; Schmidt A; Hall MN
    J Biol Chem; 2000 Nov; 275(47):37011-20. PubMed ID: 10973982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae.
    Wedaman KP; Reinke A; Anderson S; Yates J; McCaffery JM; Powers T
    Mol Biol Cell; 2003 Mar; 14(3):1204-20. PubMed ID: 12631735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC; Heitman J
    J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Saccharomyces cerevisiae dna2 mutants suggests a role for the helicase late in S phase.
    Fiorentino DF; Crabtree GR
    Mol Biol Cell; 1997 Dec; 8(12):2519-37. PubMed ID: 9398673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
    Cardenas ME; Heitman J
    EMBO J; 1995 Dec; 14(23):5892-907. PubMed ID: 8846782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
    Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
    J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
    Loewith R; Jacinto E; Wullschleger S; Lorberg A; Crespo JL; Bonenfant D; Oppliger W; Jenoe P; Hall MN
    Mol Cell; 2002 Sep; 10(3):457-68. PubMed ID: 12408816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of TOR signaling complexes: more TORC for the cell growth engine.
    Abraham RT
    Cell; 2002 Oct; 111(1):9-12. PubMed ID: 12372295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM; Cardenas ME; Heitman J
    Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins.
    Shamji AF; Kuruvilla FG; Schreiber SL
    Curr Biol; 2000 Dec 14-28; 10(24):1574-81. PubMed ID: 11137008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cell integrity pathway by rapamycin-sensitive TOR function in budding yeast.
    Torres J; Di Como CJ; Herrero E; De La Torre-Ruiz MA
    J Biol Chem; 2002 Nov; 277(45):43495-504. PubMed ID: 12171921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.